feed,title,long_url,short_url
Benzinga,Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement,https://benzinga.com/pressreleases/21/02/g19819294/onconova-therapeutics-regains-compliance-with-nasdaq-continued-listing-requirement,
Benzinga,Recce Pharmaceuticals Applies for Dual Listing on FSE (Frankfurt Stock Exchange),https://benzinga.com/pressreleases/21/02/g19819255/recce-pharmaceuticals-applies-for-dual-listing-on-fse-frankfurt-stock-exchange,
